Optimized clinical performance of growth hormone with an expanded genetic code

The ribosomal incorporation of nonnative amino acids into polypeptides in living cells provides the opportunity to endow therapeutic proteins with unique pharmacological properties. We report here the first clinical study of a biosynthetic protein produced using an expanded genetic code. Incorporati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2011-05, Vol.108 (22), p.9060-9065
Hauptverfasser: Cho, Ho, Daniel, Tom, Buechler, Ying Ji, Litzinger, David C, Maio, Zhenwei, Putnam, Anna-Maria Hays, Kraynov, Vadim S, Sim, Bee-Cheng, Bussell, Stuart, Javahishvili, Tsotne, Kaphle, Sami, Viramontes, Guillermo, Ong, Mike, Chu, Stephanie, GC, Becky, Lieu, Ricky, Knudsen, Nick, Castiglioni, Paola, Norman, Thea C, Axelrod, Douglas W, Hoffman, Andrew R, Schultz, Peter G, DiMarchi, Richard D, Kimmel, Bruce E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 9065
container_issue 22
container_start_page 9060
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 108
creator Cho, Ho
Daniel, Tom
Buechler, Ying Ji
Litzinger, David C
Maio, Zhenwei
Putnam, Anna-Maria Hays
Kraynov, Vadim S
Sim, Bee-Cheng
Bussell, Stuart
Javahishvili, Tsotne
Kaphle, Sami
Viramontes, Guillermo
Ong, Mike
Chu, Stephanie
GC, Becky
Lieu, Ricky
Knudsen, Nick
Castiglioni, Paola
Norman, Thea C
Axelrod, Douglas W
Hoffman, Andrew R
Schultz, Peter G
DiMarchi, Richard D
Kimmel, Bruce E
description The ribosomal incorporation of nonnative amino acids into polypeptides in living cells provides the opportunity to endow therapeutic proteins with unique pharmacological properties. We report here the first clinical study of a biosynthetic protein produced using an expanded genetic code. Incorporation of p-acetylphenylalanine (pAcF) at distinct locations in human growth hormone (hGH) allowed site-specific conjugation with polyethylene glycol (PEG) to produce homogeneous hGH variants. A mono-PEGylated mutant hGH modified at residue 35 demonstrated favorable pharmacodynamic properties in GH-deficient rats. Clinical studies in GH-deficient adults demonstrated efficacy and safety comparable to native human growth hormone therapy but with increased potency and reduced injection frequency. This example illustrates the utility of nonnative amino acids to optimize protein therapeutics in an analogous fashion to the use of medicinal chemistry to optimize conventional natural products, low molecular weight drugs, and peptides.
doi_str_mv 10.1073/pnas.1100387108
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmed_primary_21576502</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>25831087</jstor_id><sourcerecordid>25831087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c521t-658034ba8c6c73bcb4a242b7d27e9208d54717e91699768a5b8a725eca028ff53</originalsourceid><addsrcrecordid>eNpdkc1P3DAQxS1UVBbaM6e2ERdOgbETf12QKkQBCcGBcrYcx9n1KrFTO1ta_vp6tQvb9mR7_JunefMQOsZwhoFX56PX6QxjgEpwDGIPzTBIXLJawjs0AyC8FDWpD9BhSksAkFTAe3RAMOWMApmh-4dxcoN7sW1heued0X0x2tiFOGhvbBG6Yh7D87QoFrkUvC2eXX5oX9hfo_Zt7ptbbydnChNa-wHtd7pP9uP2PEJP366-X96Udw_Xt5df70pDCZ5Klseo6kYLwwyvGtPUmtSk4S3hVhIQLa05zlfMpORMaNoIzQm1RgMRXUerI3Sx0R1XzWBbY_0Uda_G6AYdf6ugnfr3x7uFmoefqsprI3ItcLoViOHHyqZJDS4Z2_fa27BKSjKBGUjGM3nyH7kMq-izOyXyeJhmJkPnG8jEkFK03dsoGNQ6KbVOSu2Syh2f_3bwxr9Gk4EvW2DduZMTihAlgUEmPm2IZZpC3ClQkV0KvlPodFB6Hl1ST48Esi_AMi8Bqj_OAKyB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>869915673</pqid></control><display><type>article</type><title>Optimized clinical performance of growth hormone with an expanded genetic code</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Cho, Ho ; Daniel, Tom ; Buechler, Ying Ji ; Litzinger, David C ; Maio, Zhenwei ; Putnam, Anna-Maria Hays ; Kraynov, Vadim S ; Sim, Bee-Cheng ; Bussell, Stuart ; Javahishvili, Tsotne ; Kaphle, Sami ; Viramontes, Guillermo ; Ong, Mike ; Chu, Stephanie ; GC, Becky ; Lieu, Ricky ; Knudsen, Nick ; Castiglioni, Paola ; Norman, Thea C ; Axelrod, Douglas W ; Hoffman, Andrew R ; Schultz, Peter G ; DiMarchi, Richard D ; Kimmel, Bruce E</creator><creatorcontrib>Cho, Ho ; Daniel, Tom ; Buechler, Ying Ji ; Litzinger, David C ; Maio, Zhenwei ; Putnam, Anna-Maria Hays ; Kraynov, Vadim S ; Sim, Bee-Cheng ; Bussell, Stuart ; Javahishvili, Tsotne ; Kaphle, Sami ; Viramontes, Guillermo ; Ong, Mike ; Chu, Stephanie ; GC, Becky ; Lieu, Ricky ; Knudsen, Nick ; Castiglioni, Paola ; Norman, Thea C ; Axelrod, Douglas W ; Hoffman, Andrew R ; Schultz, Peter G ; DiMarchi, Richard D ; Kimmel, Bruce E</creatorcontrib><description>The ribosomal incorporation of nonnative amino acids into polypeptides in living cells provides the opportunity to endow therapeutic proteins with unique pharmacological properties. We report here the first clinical study of a biosynthetic protein produced using an expanded genetic code. Incorporation of p-acetylphenylalanine (pAcF) at distinct locations in human growth hormone (hGH) allowed site-specific conjugation with polyethylene glycol (PEG) to produce homogeneous hGH variants. A mono-PEGylated mutant hGH modified at residue 35 demonstrated favorable pharmacodynamic properties in GH-deficient rats. Clinical studies in GH-deficient adults demonstrated efficacy and safety comparable to native human growth hormone therapy but with increased potency and reduced injection frequency. This example illustrates the utility of nonnative amino acids to optimize protein therapeutics in an analogous fashion to the use of medicinal chemistry to optimize conventional natural products, low molecular weight drugs, and peptides.</description><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.1100387108</identifier><identifier>PMID: 21576502</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>adults ; Amino acids ; Animals ; Biological Sciences ; biopharmaceuticals ; Body weight ; Cells ; clinical trials ; Dosage ; Dose-Response Relationship, Drug ; Drugs ; Endocrinology - methods ; Genetic code ; Genetic Variation ; Genetics ; Growth hormone ; Growth hormones ; hormone replacement therapy ; human growth ; Human Growth Hormone - genetics ; Human Growth Hormone - pharmacology ; Humans ; Male ; Medical treatment ; medicinal properties ; molecular weight ; mutants ; Mutation ; natural products ; Peptides ; Peptides - chemistry ; Pharmacodynamics ; Pharmacokinetics ; Phenylalanine - analogs &amp; derivatives ; Phenylalanine - chemistry ; Placebos ; Polyethylene glycol ; Polyethylene Glycols - chemistry ; Polymers - chemistry ; polypeptides ; Protein Engineering - methods ; Protein synthesis ; Rats ; Rats, Sprague-Dawley ; Ribosomes - chemistry ; Rodents ; somatotropin ; Tibia</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (22), p.9060-9065</ispartof><rights>Copyright National Academy of Sciences May 31, 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c521t-658034ba8c6c73bcb4a242b7d27e9208d54717e91699768a5b8a725eca028ff53</citedby><cites>FETCH-LOGICAL-c521t-658034ba8c6c73bcb4a242b7d27e9208d54717e91699768a5b8a725eca028ff53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.pnas.org/content/108/22.cover.gif</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/25831087$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/25831087$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,723,776,780,799,881,27901,27902,53766,53768,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21576502$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cho, Ho</creatorcontrib><creatorcontrib>Daniel, Tom</creatorcontrib><creatorcontrib>Buechler, Ying Ji</creatorcontrib><creatorcontrib>Litzinger, David C</creatorcontrib><creatorcontrib>Maio, Zhenwei</creatorcontrib><creatorcontrib>Putnam, Anna-Maria Hays</creatorcontrib><creatorcontrib>Kraynov, Vadim S</creatorcontrib><creatorcontrib>Sim, Bee-Cheng</creatorcontrib><creatorcontrib>Bussell, Stuart</creatorcontrib><creatorcontrib>Javahishvili, Tsotne</creatorcontrib><creatorcontrib>Kaphle, Sami</creatorcontrib><creatorcontrib>Viramontes, Guillermo</creatorcontrib><creatorcontrib>Ong, Mike</creatorcontrib><creatorcontrib>Chu, Stephanie</creatorcontrib><creatorcontrib>GC, Becky</creatorcontrib><creatorcontrib>Lieu, Ricky</creatorcontrib><creatorcontrib>Knudsen, Nick</creatorcontrib><creatorcontrib>Castiglioni, Paola</creatorcontrib><creatorcontrib>Norman, Thea C</creatorcontrib><creatorcontrib>Axelrod, Douglas W</creatorcontrib><creatorcontrib>Hoffman, Andrew R</creatorcontrib><creatorcontrib>Schultz, Peter G</creatorcontrib><creatorcontrib>DiMarchi, Richard D</creatorcontrib><creatorcontrib>Kimmel, Bruce E</creatorcontrib><title>Optimized clinical performance of growth hormone with an expanded genetic code</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><description>The ribosomal incorporation of nonnative amino acids into polypeptides in living cells provides the opportunity to endow therapeutic proteins with unique pharmacological properties. We report here the first clinical study of a biosynthetic protein produced using an expanded genetic code. Incorporation of p-acetylphenylalanine (pAcF) at distinct locations in human growth hormone (hGH) allowed site-specific conjugation with polyethylene glycol (PEG) to produce homogeneous hGH variants. A mono-PEGylated mutant hGH modified at residue 35 demonstrated favorable pharmacodynamic properties in GH-deficient rats. Clinical studies in GH-deficient adults demonstrated efficacy and safety comparable to native human growth hormone therapy but with increased potency and reduced injection frequency. This example illustrates the utility of nonnative amino acids to optimize protein therapeutics in an analogous fashion to the use of medicinal chemistry to optimize conventional natural products, low molecular weight drugs, and peptides.</description><subject>adults</subject><subject>Amino acids</subject><subject>Animals</subject><subject>Biological Sciences</subject><subject>biopharmaceuticals</subject><subject>Body weight</subject><subject>Cells</subject><subject>clinical trials</subject><subject>Dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drugs</subject><subject>Endocrinology - methods</subject><subject>Genetic code</subject><subject>Genetic Variation</subject><subject>Genetics</subject><subject>Growth hormone</subject><subject>Growth hormones</subject><subject>hormone replacement therapy</subject><subject>human growth</subject><subject>Human Growth Hormone - genetics</subject><subject>Human Growth Hormone - pharmacology</subject><subject>Humans</subject><subject>Male</subject><subject>Medical treatment</subject><subject>medicinal properties</subject><subject>molecular weight</subject><subject>mutants</subject><subject>Mutation</subject><subject>natural products</subject><subject>Peptides</subject><subject>Peptides - chemistry</subject><subject>Pharmacodynamics</subject><subject>Pharmacokinetics</subject><subject>Phenylalanine - analogs &amp; derivatives</subject><subject>Phenylalanine - chemistry</subject><subject>Placebos</subject><subject>Polyethylene glycol</subject><subject>Polyethylene Glycols - chemistry</subject><subject>Polymers - chemistry</subject><subject>polypeptides</subject><subject>Protein Engineering - methods</subject><subject>Protein synthesis</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Ribosomes - chemistry</subject><subject>Rodents</subject><subject>somatotropin</subject><subject>Tibia</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1P3DAQxS1UVBbaM6e2ERdOgbETf12QKkQBCcGBcrYcx9n1KrFTO1ta_vp6tQvb9mR7_JunefMQOsZwhoFX56PX6QxjgEpwDGIPzTBIXLJawjs0AyC8FDWpD9BhSksAkFTAe3RAMOWMApmh-4dxcoN7sW1heued0X0x2tiFOGhvbBG6Yh7D87QoFrkUvC2eXX5oX9hfo_Zt7ptbbydnChNa-wHtd7pP9uP2PEJP366-X96Udw_Xt5df70pDCZ5Klseo6kYLwwyvGtPUmtSk4S3hVhIQLa05zlfMpORMaNoIzQm1RgMRXUerI3Sx0R1XzWBbY_0Uda_G6AYdf6ugnfr3x7uFmoefqsprI3ItcLoViOHHyqZJDS4Z2_fa27BKSjKBGUjGM3nyH7kMq-izOyXyeJhmJkPnG8jEkFK03dsoGNQ6KbVOSu2Syh2f_3bwxr9Gk4EvW2DduZMTihAlgUEmPm2IZZpC3ClQkV0KvlPodFB6Hl1ST48Esi_AMi8Bqj_OAKyB</recordid><startdate>20110531</startdate><enddate>20110531</enddate><creator>Cho, Ho</creator><creator>Daniel, Tom</creator><creator>Buechler, Ying Ji</creator><creator>Litzinger, David C</creator><creator>Maio, Zhenwei</creator><creator>Putnam, Anna-Maria Hays</creator><creator>Kraynov, Vadim S</creator><creator>Sim, Bee-Cheng</creator><creator>Bussell, Stuart</creator><creator>Javahishvili, Tsotne</creator><creator>Kaphle, Sami</creator><creator>Viramontes, Guillermo</creator><creator>Ong, Mike</creator><creator>Chu, Stephanie</creator><creator>GC, Becky</creator><creator>Lieu, Ricky</creator><creator>Knudsen, Nick</creator><creator>Castiglioni, Paola</creator><creator>Norman, Thea C</creator><creator>Axelrod, Douglas W</creator><creator>Hoffman, Andrew R</creator><creator>Schultz, Peter G</creator><creator>DiMarchi, Richard D</creator><creator>Kimmel, Bruce E</creator><general>National Academy of Sciences</general><general>National Acad Sciences</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>5PM</scope></search><sort><creationdate>20110531</creationdate><title>Optimized clinical performance of growth hormone with an expanded genetic code</title><author>Cho, Ho ; Daniel, Tom ; Buechler, Ying Ji ; Litzinger, David C ; Maio, Zhenwei ; Putnam, Anna-Maria Hays ; Kraynov, Vadim S ; Sim, Bee-Cheng ; Bussell, Stuart ; Javahishvili, Tsotne ; Kaphle, Sami ; Viramontes, Guillermo ; Ong, Mike ; Chu, Stephanie ; GC, Becky ; Lieu, Ricky ; Knudsen, Nick ; Castiglioni, Paola ; Norman, Thea C ; Axelrod, Douglas W ; Hoffman, Andrew R ; Schultz, Peter G ; DiMarchi, Richard D ; Kimmel, Bruce E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c521t-658034ba8c6c73bcb4a242b7d27e9208d54717e91699768a5b8a725eca028ff53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>adults</topic><topic>Amino acids</topic><topic>Animals</topic><topic>Biological Sciences</topic><topic>biopharmaceuticals</topic><topic>Body weight</topic><topic>Cells</topic><topic>clinical trials</topic><topic>Dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drugs</topic><topic>Endocrinology - methods</topic><topic>Genetic code</topic><topic>Genetic Variation</topic><topic>Genetics</topic><topic>Growth hormone</topic><topic>Growth hormones</topic><topic>hormone replacement therapy</topic><topic>human growth</topic><topic>Human Growth Hormone - genetics</topic><topic>Human Growth Hormone - pharmacology</topic><topic>Humans</topic><topic>Male</topic><topic>Medical treatment</topic><topic>medicinal properties</topic><topic>molecular weight</topic><topic>mutants</topic><topic>Mutation</topic><topic>natural products</topic><topic>Peptides</topic><topic>Peptides - chemistry</topic><topic>Pharmacodynamics</topic><topic>Pharmacokinetics</topic><topic>Phenylalanine - analogs &amp; derivatives</topic><topic>Phenylalanine - chemistry</topic><topic>Placebos</topic><topic>Polyethylene glycol</topic><topic>Polyethylene Glycols - chemistry</topic><topic>Polymers - chemistry</topic><topic>polypeptides</topic><topic>Protein Engineering - methods</topic><topic>Protein synthesis</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Ribosomes - chemistry</topic><topic>Rodents</topic><topic>somatotropin</topic><topic>Tibia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cho, Ho</creatorcontrib><creatorcontrib>Daniel, Tom</creatorcontrib><creatorcontrib>Buechler, Ying Ji</creatorcontrib><creatorcontrib>Litzinger, David C</creatorcontrib><creatorcontrib>Maio, Zhenwei</creatorcontrib><creatorcontrib>Putnam, Anna-Maria Hays</creatorcontrib><creatorcontrib>Kraynov, Vadim S</creatorcontrib><creatorcontrib>Sim, Bee-Cheng</creatorcontrib><creatorcontrib>Bussell, Stuart</creatorcontrib><creatorcontrib>Javahishvili, Tsotne</creatorcontrib><creatorcontrib>Kaphle, Sami</creatorcontrib><creatorcontrib>Viramontes, Guillermo</creatorcontrib><creatorcontrib>Ong, Mike</creatorcontrib><creatorcontrib>Chu, Stephanie</creatorcontrib><creatorcontrib>GC, Becky</creatorcontrib><creatorcontrib>Lieu, Ricky</creatorcontrib><creatorcontrib>Knudsen, Nick</creatorcontrib><creatorcontrib>Castiglioni, Paola</creatorcontrib><creatorcontrib>Norman, Thea C</creatorcontrib><creatorcontrib>Axelrod, Douglas W</creatorcontrib><creatorcontrib>Hoffman, Andrew R</creatorcontrib><creatorcontrib>Schultz, Peter G</creatorcontrib><creatorcontrib>DiMarchi, Richard D</creatorcontrib><creatorcontrib>Kimmel, Bruce E</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cho, Ho</au><au>Daniel, Tom</au><au>Buechler, Ying Ji</au><au>Litzinger, David C</au><au>Maio, Zhenwei</au><au>Putnam, Anna-Maria Hays</au><au>Kraynov, Vadim S</au><au>Sim, Bee-Cheng</au><au>Bussell, Stuart</au><au>Javahishvili, Tsotne</au><au>Kaphle, Sami</au><au>Viramontes, Guillermo</au><au>Ong, Mike</au><au>Chu, Stephanie</au><au>GC, Becky</au><au>Lieu, Ricky</au><au>Knudsen, Nick</au><au>Castiglioni, Paola</au><au>Norman, Thea C</au><au>Axelrod, Douglas W</au><au>Hoffman, Andrew R</au><au>Schultz, Peter G</au><au>DiMarchi, Richard D</au><au>Kimmel, Bruce E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimized clinical performance of growth hormone with an expanded genetic code</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2011-05-31</date><risdate>2011</risdate><volume>108</volume><issue>22</issue><spage>9060</spage><epage>9065</epage><pages>9060-9065</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><abstract>The ribosomal incorporation of nonnative amino acids into polypeptides in living cells provides the opportunity to endow therapeutic proteins with unique pharmacological properties. We report here the first clinical study of a biosynthetic protein produced using an expanded genetic code. Incorporation of p-acetylphenylalanine (pAcF) at distinct locations in human growth hormone (hGH) allowed site-specific conjugation with polyethylene glycol (PEG) to produce homogeneous hGH variants. A mono-PEGylated mutant hGH modified at residue 35 demonstrated favorable pharmacodynamic properties in GH-deficient rats. Clinical studies in GH-deficient adults demonstrated efficacy and safety comparable to native human growth hormone therapy but with increased potency and reduced injection frequency. This example illustrates the utility of nonnative amino acids to optimize protein therapeutics in an analogous fashion to the use of medicinal chemistry to optimize conventional natural products, low molecular weight drugs, and peptides.</abstract><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>21576502</pmid><doi>10.1073/pnas.1100387108</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (22), p.9060-9065
issn 0027-8424
1091-6490
language eng
recordid cdi_pubmed_primary_21576502
source Jstor Complete Legacy; MEDLINE; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects adults
Amino acids
Animals
Biological Sciences
biopharmaceuticals
Body weight
Cells
clinical trials
Dosage
Dose-Response Relationship, Drug
Drugs
Endocrinology - methods
Genetic code
Genetic Variation
Genetics
Growth hormone
Growth hormones
hormone replacement therapy
human growth
Human Growth Hormone - genetics
Human Growth Hormone - pharmacology
Humans
Male
Medical treatment
medicinal properties
molecular weight
mutants
Mutation
natural products
Peptides
Peptides - chemistry
Pharmacodynamics
Pharmacokinetics
Phenylalanine - analogs & derivatives
Phenylalanine - chemistry
Placebos
Polyethylene glycol
Polyethylene Glycols - chemistry
Polymers - chemistry
polypeptides
Protein Engineering - methods
Protein synthesis
Rats
Rats, Sprague-Dawley
Ribosomes - chemistry
Rodents
somatotropin
Tibia
title Optimized clinical performance of growth hormone with an expanded genetic code
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T21%3A43%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimized%20clinical%20performance%20of%20growth%20hormone%20with%20an%20expanded%20genetic%20code&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Cho,%20Ho&rft.date=2011-05-31&rft.volume=108&rft.issue=22&rft.spage=9060&rft.epage=9065&rft.pages=9060-9065&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.1100387108&rft_dat=%3Cjstor_pubme%3E25831087%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=869915673&rft_id=info:pmid/21576502&rft_jstor_id=25831087&rfr_iscdi=true